Dwight Gorham News Today

SAINT LAURENT, Quebec, April 08, 2024 -- IntelGenx Corp.  today announced that Montelukast VersaFilm® has been administered to the first Parkinson’s Disease patients in the Phase 2 clinical...

SAINT LAURENT, Quebec, April 05, 2024 -- IntelGenx Corp. today announced that its co-developer, Chemo Research SL, through its agent and affiliate, Xiromed LLC , has received a Complete Response...

SAINT LAURENT, Quebec, Feb. 20, 2024 -- IntelGenx Corp. today announced the launch of a Regulation A offering of up to 2,000,000 shares of Series A Convertible Cumulative Preferred Stock , par...

Operator: Greetings. Welcome to IntelGenx’s Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

06.11.2023 - IntelGenx to Manufacture and Supply Three New Filmstrip Products: CBD20, THC10, and THC10:CBD10SAINT LAURENT, Quebec, Nov. 06, 2023 (GLOBE NEWSWIRE) - IntelGenx Corp. (TSX:IGX)(OTCQB:IGXT) (the Company or IntelGenx) today announced that it and ...

SAINT LAURENT, Quebec, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical...

Receives first purchase order from Gensco® PharmaSAINT LAURENT, Quebec, Sept. 21, 2023 -- IntelGenx Corp. today announced that it has received the first purchase order for RIZAFILM®1 from its...

SAINT LAURENT, Quebec, Sept. 19, 2023 -- IntelGenx Corp. today provided a regulatory update on Buprenorphine Buccal Film, for which an abbreviated new drug application has been filed with the...

IntelGenx Technologies Corp. (TSX: IGX) (OTC: IGXT), a drug delivery company focused on the development and manufacturing of pharmaceutical films, reported its financial results on Monday for the second quarter ending on June 30, 2023.

Operator: Greetings. And welcome to the IntelGenx Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.